Nausea and vomiting are considered as two most distressing side effects of cancer chemotherapy. Due to the arrival of antiemetic agents since their inception in 1997, several discussions and studies have been conducted and recommendations are proposed. This guideline may be helpful for the oncologist to manage nausea and vomiting associated with chemo-and radiotherapy. In the initial part, the guideline categorizes all the anti-neoplastic agents based on their emetogenic potential where they are divided as high, moderate, low and minimal categories.
Furthermore, it also categorizes the oral anti-neoplastic agents based on their high, moderate, low and minimal emetogenic potential. These observations are based on the published scientific evidence and clinical trials and outcomes. The guideline further recommends management of the following clinical scenarios, Acute nausea and vomiting…
